Follow the Rising Star Talk of Thomas via live stream on 21 October 2019 at 4.20 pm: "Understanding pathophysiology in order to identify novel therapeutic strategies for chronic liver diseases”.
Every year the National Societies Committee and the UEG Scientific Committee jointly select 6-8 emerging clinical scientists as Rising Stars. These are promising candidates under the age of 40 with an excellent scientific track record and internationally recognized and independent research.
The United European Gastroenterology (UEG), represents more than 30,000 medical specialists from every field in gastroenterology. The UEG Week attracts around 14,000 conference participants each year.
Thomas Reiberger, born 1982, joined the LBI-RUD and CeMM in 2018 as an Adjunct PI. After obtaining his MD at the Medical University of Vienna, he did a first postdoc at the Department of Pathophysiology at the Medical University of Vienna, where he performed his first studies in the field of Liver Cell Biology. During his residency for Internal Medicine at the Divison of Gastroenterology and Hepatology at the Medical University of Vienna, Thomas Reiberger followed the career of a physician scientist and focused his translational studies on portal hypertension and fibrosis in patients with viral hepatitis. Next to the clinic he established the Vienna Hepatic Experimental (HEPEX) Laboratory at the Medical University of Vienna. In 2011 he received his Venia docendi and 2012 he obtained his board certification for Internal Medicine. After another postdoctoral fellowship in the United States from 2012 to 2015, Thomas Reiberger was appointed as Associate Professor of Gastroenterology and Hepatology at the Medical University of Vienna.
More information: https://www.meduniwien.ac.at/web/ueber-uns/news/